SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    EASL Recommendations on Treatment of Hepatitis C 2015, Journal of Hepatology, 2015,

    CrossRef

  2. 2
    Akihisa Tatsumi, Shinya Maekawa, Mitsuaki Sato, Nobutoshi Komatsu, Mika Miura, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto, Nobuyuki Enomoto, Liver stiffness measurement for risk assessment of hepatocellular carcinoma, Hepatology Research, 2015, 45, 5
  3. You have free access to this content3
    Naoki Hiramatsu, Tsugiko Oze, Tetsuo Takehara, Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy, Hepatology Research, 2015, 45, 2
  4. 4
    Zara Zelenko, Emily Jane Gallagher, Diabetes and Cancer, Endocrinology and Metabolism Clinics of North America, 2014, 43, 1, 167

    CrossRef

  5. 5
    Laure Elkrief, Pascale Chouinard, Noelle Bendersky, David Hajage, Béatrice Larroque, Gérard Babany, Blaise Kutala, Claire Francoz, Nathalie Boyer, Richard Moreau, François Durand, Patrick Marcellin, Pierre-Emmanuel Rautou, Dominique Valla, Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C, Hepatology, 2014, 60, 3
  6. 6
    Hashem B. El-Serag, Fasiha Kanwal, Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?, Hepatology, 2014, 60, 5
  7. 7
    Isao Kamae, Hiromitsu Kumada, Masahiro Kobayashi, Thomas Ward, Samantha Webster, Yong Yuan, Anupama Kalsekar, Sachie Inoue, Ann Tang, Phil McEwan, Epidemiology, treatment and health economics of Hepatitis C in Japan (Review), Kanzo, 2014, 55, 10, 589

    CrossRef

  8. 8
    Phil McEwan, Thomas Ward, Samantha Webster, Yong Yuan, Anupama Kalsekar, Kristine Broglio, Isao Kamae, Melanie Quintana, Scott M. Berry, Masahiro Kobayashi, Sachie Inoue, Ann Tang, Hiromitsu Kumada, Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b, Value in Health Regional Issues, 2014, 3, 136

    CrossRef

  9. 9
    Francesco Negro, Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases, Journal of Hepatology, 2014, 61, 1, S69

    CrossRef

  10. 10
    Yasuji Arase, Mariko Kobayashi, Yusuke Kawamura, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Masahiro Kobayashi, Hitomi Sezaki, Satoshi Saito, Tetsuya Hosaka, Kenji Ikeda, Hiromitsu Kumada, Tetsuro Kobayashi, Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C, Journal of Medical Virology, 2014, 86, 1
  11. 11
    Jin Ding, Hongyang Wang, Multiple interactive factors in hepatocarcinogenesis, Cancer Letters, 2014, 346, 1, 17

    CrossRef

  12. 12
    Massimo Colombo, Massimo Iavarone, Role of antiviral treatment for HCC prevention, Best Practice & Research Clinical Gastroenterology, 2014, 28, 5, 771

    CrossRef

  13. 13
    Massimo Colombo, Simone Strasser, Christophe Moreno, Paulo Abrao Ferreira, Petr Urbanek, Inmaculada Fernández, Djamal Abdurakmonov, Adrian Streinu-Cercel, Anke Verheyen, Wafae Iraqi, Ralph DeMasi, Andrew Hill, Isabelle Lonjon-Domanec, Heiner Wedemeyer, Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program, Journal of Hepatology, 2014, 61, 5, 976

    CrossRef

  14. 14
    Z. M. Younossi, F. Kanwal, S. Saab, K. A. Brown, H. B. El-Serag, W. R. Kim, A. Ahmed, M. Kugelmas, S. C. Gordon, The impact of hepatitis C burden: an evidence-based approach, Alimentary Pharmacology & Therapeutics, 2014, 39, 5
  15. 15
    Nicolas Goossens, Francesco Negro, The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis C, Clinics in Liver Disease, 2014, 18, 1, 147

    CrossRef

  16. 16
    Takashi Nakahara, Hideyuki Hyogo, Masato Yoneda, Yoshio Sumida, Yuichiro Eguchi, Hideki Fujii, Masafumi Ono, Takumi Kawaguchi, Kento Imajo, Hiroshi Aikata, Saiyu Tanaka, Kazuyuki Kanemasa, Kazuma Fujimoto, Keizo Anzai, Toshiji Saibara, Michio Sata, Atushi Nakajima, Yoshito Itoh, Kazuaki Chayama, Takeshi Okanoue, Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients, Journal of Gastroenterology, 2014, 49, 11, 1477

    CrossRef

  17. 17
    Emily J. Gallagher, Derek LeRoith, Diabetes, antihyperglycemic medications and cancer risk, Current Opinion in Endocrinology & Diabetes and Obesity, 2013, 20, 5, 485

    CrossRef

  18. 18
    Emily J. Gallagher, Derek LeRoith, Diabetes, Antihyperglycemic Medications and Cancer Risk: Smoke or Fire?, Endocrine Practice, 2013, 1, -1, 1

    CrossRef

  19. 19
    Siddharth Singh, Preet Paul Singh, Hepatocellular cancer risk in diabetes: Not all diabetics are the same, Hepatology, 2013, 58, 6
  20. 20
    Jean Michel Petit, Samia Hamza, Fabien Rollot, Vanessa Sigonney, Elodie Crevisy, Laurence Duvillard, Jean Jacques Raab, Jean Pierre Bronowicki, Brigitte Bernard-Chabert, Vincent Di Martino, Michel Doffoel, Helene Barraud, Carine Richou, Jean Louis Jouve, Patrick Hillon, Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis, Acta Diabetologica, 2013,

    CrossRef

  21. 21
    Yasuji Arase, Mariko Kobayashi, Hiromitsu Kumada, Reply, Hepatology, 2013, 58, 6
  22. 22
    Changhyun Lee, Jong In Yang, Hee Jin Byun, Jung Mook Kang, Seoungho Choi, Jeong Yoon Yim, Status of Primary Liver Cancer Found through Routine Health Check-up, Journal of Korean Medical Science, 2013, 28, 10, 1449

    CrossRef